Search Results - "Mini, Enrico"

Special Issue: "Gastrointestinal Cancers and Personalized Medicine".

Authors: Nobili, Stefania Mini, Enrico

Source: Journal of Personalized Medicine. Mar2022, Vol. 12 Issue 3, p338-N.PAG. 6p.

Carcinoembryonic Antigen Levels and Survival in Stage III Colon Cancer: Post hoc Analysis of the MOSAIC and PETACC-8 Trials.

Authors: Auclin, Edouard Taieb, Julien Lepage, Come et al.

Source: Cancer Epidemiology, Biomarkers & Prevention. Jul2019, Vol. 28 Issue 7, p1153-1161.

Perioperative chemotherapy for gastric cancer in FLOT4.

Authors: Roviello, Giandomenico Roviello, Franco Mini, Enrico

Source: Lancet. 1/11/2020, Vol. 395 Issue 10218, pe3-e3. 1p.

Principles of Molecular Utility for CMS Classification in Colorectal Cancer Management.

Authors: Rejali, Leili Seifollahi Asl, Romina Sanjabi, Fatemeh et al.

Source: Cancers. May2023, Vol. 15 Issue 10, p2746. 31p.

Inflammation in Urological Malignancies: The Silent Killer.

Authors: Catalano, Martina Roviello, Giandomenico Santi, Raffaella et al.

Source: International Journal of Molecular Sciences. Jan2023, Vol. 24 Issue 1, p866. 24p.

Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs.

Authors: Lulli, Matteo Napoli, Cristina Landini, Ida et al.

Source: International Journal of Molecular Sciences. Nov2022, Vol. 23 Issue 21, p13431. 15p.

Immune Checkpoint Inhibitors in Pre-Treated Gastric Cancer Patients: Results from a Literature-Based Meta-Analysis.

Authors: Roviello, Giandomenico Corona, Silvia Paola D’Angelo, Alberto et al.

Source: International Journal of Molecular Sciences. 1/15/2020, Vol. 21 Issue 2, Following p1-11. 14p. 1 Diagram, 7 Charts.

Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?

Authors: Catalano, Martina Lapucci, Andrea Nobili, Stefania et al.

Source: Cancer Chemotherapy & Pharmacology. Jan2024, Vol. 93 Issue 1, p1-9. 9p.

Corrigendum to "The molecular mechanisms of antimetastatic ruthenium compounds explored through DIGE proteomics" J Inorg Biochem 2013 Jan:118:94–9. doi:10.1016/j.jinorgbio.2012.10.003. Epub 2012 Oct 14.

Authors: Guidi, Francesca Modesti, Alessandra Landini, Ida et al.

Source: Journal of Inorganic Biochemistry. Jul2026, Vol. 280, pN.PAG-N.PAG. 1p.

Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors.

Authors: Villanucci, Alessandro Tavella, Ketty Vannini, Laura et al.

Source: Molecular & Clinical Oncology. Dec2018, Vol. 9 Issue 6, p635-639. 5p.

A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma.

Authors: Lavacchi, Daniele Nobili, Stefania Brugia, Marco et al.

Source: BMC Cancer. 10/22/2018, Vol. 18 Issue 1, p1-5. 5p. 1 Color Photograph.

Analysis of Prognostic Factors for Resected Synchronous and Metachronous Liver Metastases from Colorectal Cancer.

Authors: Bartolini, Ilenia Ringressi, Maria Novella Melli, Filippo et al.

Source: Gastroenterology Research & Practice. 7/11/2018, p1-14. 14p.

Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.

Authors: Taieb, Julien Tabernero, Josep Mini, Enrico et al.

Source: Lancet Oncology. Jul2014, Vol. 15 Issue 8, p862-873. 12p.

HLA-G 3’UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment.

Authors: Garziera, Marica Bidoli, Ettore Cecchin, Erika et al.

Source: PLoS ONE. 12/3/2015, Vol. 10 Issue 12, p1-17. 17p.

An update on antibody-drug conjugates in urothelial carcinoma: state of the art strategies and what comes next.

Authors: D'Angelo, Alberto Chapman, Robert Sirico, Marianna et al.

Source: Cancer Chemotherapy & Pharmacology. Sep2022, Vol. 90 Issue 3, p191-205. 15p.

In vitro assessment of antibody-conjugated gold nanorods for systemic injections.

Authors: Centi, Sonia Tatini, Francesca Ratto, Fulvio et al.

Source: Journal of Nanobiotechnology. 2014, Vol. 12 Issue 1, p53-78. 26p.

Identification of pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B-cell lymphoma.

Authors: Nobili, Stefania Napoli, Cristina Puccini, Benedetta et al.

Source: Leukemia & Lymphoma. Sep2014, Vol. 55 Issue 9, p2071-2078. 8p.

Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and Therapy.

Authors: Parsa, Fatemeh Ghorbani Nobili, Stefania Karimpour, Mina et al.

Source: Journal of Personalized Medicine. Mar2022, Vol. 12 Issue 3, p396-N.PAG. 26p.

Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand?

Authors: Roviello, Giandomenico Aprile, Giuseppe D'Angelo, Alberto et al.

Source: Gastric Cancer. Jul2021, Vol. 24 Issue 4, p765-779. 15p.

A potential novel drug combination for adjuvant therapy in lung cancer: reflections on an early phase of clinical development.

Authors: Roviello, Giandomenico Nobili, Stefania Mini, Enrico

Source: Journal of Chemotherapy (Taylor & Francis Ltd). Oct2019, Vol. 31 Issue 6, p295-296. 2p.